ALLR insider transaction filings
Allarity Therapeutics, Inc. — 17 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-05-14. Screen ALLR transaction legs live →
Insider transaction summary — last 90 days
No Form 4 filings for ALLR between 2026-06-24 and 2026-09-22. The table below lists the most recent filings on record.
Recent Form 4 filings — Allarity Therapeutics, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-14 | 4 | Jensen Thomas — CEO | Grant/award (A): 200,000 @ $0 | EDGAR |
| 2026-05-11 | 4 | Hoeiland Jesper — Director | Grant/award (A): 25,000 @ $0 | EDGAR |
| 2026-05-07 | 4 | McLaughlin Gerald W. — Director | Grant/award (A): 45,000 @ $0 | EDGAR |
| 2026-04-30 | 4/A | Graff Jeremy R. — See Remarks | Grant/award (A): 133,333 @ $0 | EDGAR |
| 2026-04-30 | 4 | Ervin Jeffrey S — CFO | Grant/award (A): 150,000 @ $0 | EDGAR |
| 2026-01-16 | 4 | Graff Jeremy R. — See Remarks | Grant/award (A): 133,333 @ $0 | EDGAR |
| 2025-10-02 | 4 | Graff Jeremy R. — See Remarks | Option exercise (M): 39,494 · Tax withholding (F): 14,613 @ $1.58 · Option exercise (M): 39,494 (derivative) @ $0 | EDGAR |
| 2025-01-24 | 4 | Graff Jeremy R. — CDO | Grant/award (A): 144,441 @ $0 | EDGAR |
| 2025-01-24 | 4 | Epshinsky Alexander — CFO | Grant/award (A): 29,496 @ $0 | EDGAR |
| 2025-01-24 | 4 | Jensen Thomas — CEO | Grant/award (A): 396,734 @ $0 | EDGAR |
| 2025-01-24 | 4 | Benjamin Laura — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2025-01-24 | 4/A | Benjamin Laura — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2025-01-24 | 4 | Vazzano Joseph Walter — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2025-01-24 | 4/A | Vazzano Joseph Walter — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2025-01-24 | 4 | McLaughlin Gerald W. — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2025-01-24 | 4/A | McLaughlin Gerald W. — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2024-10-01 | 4 | Graff Jeremy R. — See Remarks | Grant/award (A): 118,483 @ $2.11 | EDGAR |
Recent 8-K events — Allarity Therapeutics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-16 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-14 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-14 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-01 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-22 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-02 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-08 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-06 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-28 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-22 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ALLR returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →